Nature Genetics
Generated by DeepSeek V3.2Expansion Funnel Raw 57 → Dedup 0 → NER 0 → Enqueued 0
| Nature Genetics | |
|---|---|
| Title | Nature Genetics |
| Editor | Orli Bahcall |
| Discipline | Genetics |
| Publisher | Nature Portfolio |
| Country | United Kingdom |
| History | 1992–present |
| Frequency | Monthly |
| Openaccess | Hybrid |
| Impact | 42.4 (2022) |
| Website | https://www.nature.com/ng/ |
| ISSN | 1061-4036 |
| EISSN | 1546-1718 |
Nature Genetics. It is a monthly peer-reviewed scientific journal published by Nature Portfolio, a division of Springer Nature. The journal was established in 1992 and covers all aspects of modern genetics and genomics, with a particular emphasis on the genetic basis of human biology and disease. It is recognized as one of the most prestigious and influential journals in its field, publishing high-impact original research, reviews, and commentary.
History and background
The journal was launched in 1992 by the Nature Publishing Group, now part of Springer Nature, to address the rapidly expanding field of genetics following advances like the Human Genome Project. Its founding editor was Kevin Davies, who helped establish its editorial standards. Early volumes featured seminal work in positional cloning and linkage analysis, key methodologies of the era. Over the decades, it has chronicled the transition from Mendelian inheritance studies to the era of genome-wide association studies and next-generation sequencing.
Scope and content
The journal publishes research across the full spectrum of genetic inquiry, including studies in human genetics, model organism genetics, cancer genomics, and epigenetics. It features articles on technological innovations in DNA sequencing and genomic analysis, as well as computational approaches in bioinformatics. Regular content includes Articles, Brief Communications, Reviews, Perspectives, and News & Views commentaries. The scope explicitly connects basic genetic mechanisms to their implications for human disease and agriculture.
Impact and influence
With a 2022 impact factor of 42.4, it consistently ranks among the top journals in Genetics & Heredity. Publications within its pages have fundamentally shaped modern biomedical research, influencing fields from oncology to neurogenetics. The journal's content is frequently cited in major policy discussions and clinical guidelines. Its high visibility and rigorous standards make publication in it a significant career achievement for researchers at institutions like the Broad Institute and the Wellcome Sanger Institute.
Editorial processes and policies
The editorial team, led by Chief Editor Orli Bahcall, operates a rigorous peer-review process involving active scientists from the international community. The journal adheres to the publishing policies of Springer Nature, including those on data availability and materials sharing. It offers both subscription-based and hybrid open-access publishing options. Editorial decisions emphasize novelty, broad interest, and methodological rigor, with a commitment to publishing replication studies and null results in specific formats.
Notable articles and discoveries
Landmark papers include the first genome-wide association study for age-related macular degeneration and the identification of BRCA1 as a major breast cancer susceptibility gene. The journal published early maps of human genetic variation from the International HapMap Project and key findings from the ENCODE project. It has featured groundbreaking work on CRISPR-based genome editing and the role of non-coding DNA in regulation. Studies defining the genetic architecture of complex traits like schizophrenia and type 2 diabetes have also been prominently featured.
Related publications and initiatives
It is part of the larger Nature Portfolio, which includes sibling journals such as Nature, Nature Methods, and Nature Biotechnology. The publisher also oversees related titles like Nature Reviews Genetics and Nature Communications. Initiatives include the Nature Conferences series and online resources like the Nature Index. Content often complements research published in other high-impact journals like Science, Cell, and The American Journal of Human Genetics.